Loading clinical trials...
Loading clinical trials...
An Open-Label, Randomized, Parallel Group Study to Assess the Safety and Efficacy of Hectorol® (Doxercalciferol Capsules) in Pediatric Patients With Chronic Kidney Disease Stages 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis
Conditions
Interventions
Doxercalciferol (GZ427397)
Calcitriol
Locations
23
United States
Children's Hospital Of Alabama Site Number : 8400022
Birmingham, Alabama, United States
Cedars Sinai Medical Center Site Number : 8400033
Los Angeles, California, United States
UC DAVIS Medical Center Site Number : 8400005
Sacramento, California, United States
Yale University School of Medicine Site Number : 8400029
New Haven, Connecticut, United States
University of Miami Site Number : 8400006
Miami, Florida, United States
Nicklaus Children's Hospital Site Number : 8400008
Miami, Florida, United States
Start Date
January 19, 2017
Primary Completion Date
June 11, 2025
Completion Date
June 11, 2025
Last Updated
July 29, 2025
Lead Sponsor
Sanofi
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions